Brain Death and Live Birth: History and Bioethics.
Out of Sequence Offers: Towards Efficient, Equitable Organ Allocation.
AOOS Reflects an Opportunity for Better, Inclusive, Policy-Making.
Pregnancy Exceptionalism in End-of-Life Care: Ethical Challenges and the Need for Updated Guidance.
From End-of-Life Care to Posthumous Use: Reframing Brain Death in Pregnancy.
The Ubiquitous Pertinence of Double-Effect.
Speaking Without Knowing: Ethical Risks in Public Commentary on Patient Cases.
The Pitfalls of Media Coverage as Advocacy.
Fetal Personhood, Legal Ambiguity and the Treatment of Brain Death in Pregnancy.
Brain Death: Five Mandates to Continue Technologic Support After Death.
When Death Meets Dobbs: Fear as Policy in Organ Donation.
Highlighting Drivers of Moral Injury in Neuro-Obstetric Ethical Dilemmas.
When Life Support Becomes Unfair: Issues Related to Resource Allocation in the Smith Case.
Whole Body Gestational Donation, and the Real Life Case of Adriana Smith.
The Unattainable Standard.
Ethical Controversies in the Adriana Smith Brain Death Case: Digging in Deeper by Missing Fundamental Ethical Points.
Allocation out of Sequence, as Currently Practiced in the United States, Cannot be Ethically Justified.
When Practice Outruns Policy: The Tale of Allocation Out of Sequence.
Placing Organ Allocation Out of Sequence in the Proper Context.
The Need for Both Process and Principles in Organ Allocation Pathways.
Assumptions that Impact the Ethical Analysis of Allocation Out of Sequence.
It is AOOS All the Way Down: AI and Liver Transplantation.
The Reality and Morality of Organ Allocation Policy: It's Complicated.
Exploring Non-Utilitarian Justifications of Allocation Out of Sequence.
Ensuring Transparency in Organ Allocation out of Sequence to Address Equity Concerns: European and UK Examples.
Specifying Procedural Justice in Organ Allocation.
When Speaking of Risks Meets Responsibility: The European Ethical Framework for Shared Decision-Making in Transplantation.
Addressing Transplant Policy Shortcomings Utilizing a Relational Leadership Model.
Rare but Necessary: A Defense of Organ Allocation Out of Sequence in Heart Transplantation.
Care Over Queue: A Feminist Bioethics Defense of Allocation out of Sequence.
Constructivism, Contractualism, and Organ Allocation.
Inequity Lies in the Inability to Reject Marginal Organs.
Allocation Out of Sequence and the Mirage of Utilitarian Justice.
Honoring the Request of a Deceased Patient Who Lived in Poverty: Does the Hospital Have an Obligation to Provide Burial?
Thinking Outside the (Pine) Box: Ethics Consultation as Imaginative Inquiry and Practical Problem-Solving.
What Counts as Compelling Enough? A Crucial Question in Clinical Ethics.
When Compassion for the Bereaved Conflicts with Reality for Health Systems.
Autonomy, Truth-Telling, and Beneficence: A Jehovah's Witness Case of Conditional Refusal of Blood Products.
A Right Not to Know: Blood Products, and Surrogate Decision Making for a Jehovah's Witness Patient.
"Yes, but…": A Clinical Ethicist's Response to the Request for Clandestine Blood Transfusion.
Coercion, Questionable Autonomy, and Confidentiality Requests: Ethical Challenges in Jehovah's Witness Blood Refusals.
ELSIcon2024: Reimagining the Benefits of Genomic Sciences.
David's Sling: Bioethics Empiricism as Big Tech Goliaths Enter Genomics.
Public Value and Industry Partnerships in Data-Intensive Health Innovation.
Academic-Industry Collaborations and Genomic Databases: a "Tyranny of the Minority"?
The Power of Meso-Level Levers for Enhancing Genomics Research Partnerships.
When 'More Isn't More': The Normative and Practical Case for Improving Genetic Data Infrastructure.
The European Health Data Space as a Compass for Academic/Industry Collaborations.
Impact of the U.S. Department of Justice Data Security Program on Genomic Data Sharing.
The Value of Genomic Information: Quality Over Quantity.